CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 1,050 enrolled
Drug / intervention
DIC075V (intravenous diclofenac sodium)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00726388
NCT00726388Phase 3Completed
CompareCT.gov

An Open-Label, Multiple-Dose, Multiple-Day, Non-Randomized, Single-Arm Safety Study Of Repeat-Doses Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain

Pfizer·interventional·Posted Jul 31, 2008·Updated Oct 13, 2021

In Brief

A Phase 3 clinical trial evaluating DIC075V (intravenous diclofenac sodium) for Pain, Postoperative. Completed, enrolled 1,050 participants across 46 sites.

Detailed Summary

This is an open-label, multiple-dose, safety study of DIC075V in patients with acute post-operative pain following abdominal or orthopedic surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 31, 2008
Enrollment StartSep 15, 2008
Primary CompletionMay 8, 2009
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 17.9 years ago

Interventions

DIC075V (intravenous diclofenac sodium)drug

multiple doses up to 5 days